Angeles Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Angeles Wealth Management's WST Position: Q3 2026 in Review
Angeles Wealth Management reduced its West Pharmaceutical (WST) stake by 3.4% in Q3 2026, selling an estimated $12.4K and leaving 999 shares worth $370K. The position accounts for 0.02% of the portfolio, ranked #321.
Angeles Wealth Management first reported a position in WST in Q2 2025 and has held it in 6 quarters since. The position peaked at $371K in Q2 2026. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Angeles Wealth Management held 999 shares of West Pharmaceutical worth $370K as of Q3 2026.
- Angeles Wealth Management sold 35 West Pharmaceutical shares in Q3 2026, an estimated $12.4K.
- West Pharmaceutical made up 0.02% of Angeles Wealth Management's portfolio in Q3 2026, its #321 holding.
- Angeles Wealth Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
- Angeles Wealth Management's West Pharmaceutical position peaked at $371K in Q2 2026.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Angeles Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.